Common Contracts
3 similar null contracts by Endra Inc., ENDRA Life Sciences Inc.
WARRANT TO PURCHASE COMMON STOCK OF ENDRA, INC.ENDRA Life Sciences Inc. • November 21st, 2016 • Electromedical & electrotherapeutic apparatus • California
This certifies that __________________, or assigns (collectively, the “Holder”), for value received, is entitled to purchase, at an exercise price per share equal to $_____ (the “Exercise Price”), from ENDRA, INC., a Delaware corporation (the “Company”), up to ____________ (_________) fully paid and nonassessable shares of the Company’s Common Stock (the “Common Stock”). This Warrant shall be exercisable at any time from time to time from and after the date of issuance hereof (the “Issuance Date”) up to and including 5:00 p.m. (Pacific Time) on the first to occur of (i) the second (2nd) anniversary of the Issuance Date or (ii) on the closing date of a financing transaction resulting in the Company receiving gross proceeds of at least $5.0 million at a valuation, calculated prior to the date of consummation of the financing, of at least $10.0 million (a “Qualified Financing”) (such earlier date being referred to herein as the “Expiration Date”), upon surrender to the Company at its prin
WARRANT TO PURCHASE COMMON STOCK OF ENDRA, INC.Endra Inc. • September 21st, 2016 • Electromedical & electrotherapeutic apparatus • California
This certifies that __________________, or assigns (collectively, the “Holder”), for value received, is entitled to purchase, at an exercise price per share equal to $_____ (the “Exercise Price”), from ENDRA, INC., a Delaware corporation (the “Company”), up to ____________ (_________) fully paid and nonassessable shares of the Company’s Common Stock (the “Common Stock”). This Warrant shall be exercisable at any time from time to time from and after the date of issuance hereof (the “Issuance Date”) up to and including 5:00 p.m. (Pacific Time) on the first to occur of (i) the second (2nd) anniversary of the Issuance Date or (ii) on the closing date of a financing transaction resulting in the Company receiving gross proceeds of at least $5.0 million at a valuation, calculated prior to the date of consummation of the financing, of at least $10.0 million (a “Qualified Financing”) (such earlier date being referred to herein as the “Expiration Date”), upon surrender to the Company at its prin
WARRANT TO PURCHASE COMMON STOCK OF ENDRA, INC.Endra Inc. • September 21st, 2016 • Electromedical & electrotherapeutic apparatus • Delaware
This certifies that ___________, or assigns (collectively, the “Holder”), for value received, is entitled to purchase, at an exercise price per share equal to $5.72 (the “Exercise Price”), from ENDRA, INC., a Delaware corporation (the “Company”), up to ___________ (___________) fully paid and nonassessable shares (the “Warrant Shares”) of the Company’s Common Stock (the “Common Stock”). This Warrant shall be exercisable at any time from time to time from and after the date of issuance hereof (the “Issuance Date”) up to and including 5:00 p.m. (Pacific Time) on the fifth (5th) anniversary of the Issuance Date (such date being referred to herein as the “Expiration Date”), upon surrender to the Company at its principal office (or at such other location as the Company may advise the Holder in writing) of this Warrant properly endorsed with (i) the Form of Subscription attached hereto duly completed and executed and (ii) if applicable, payment pursuant to Section 4 of the aggregate Exercise
